A new computer tool has been developed to predict how some cancers may respond to an investigational treatment before it has even been administered to a patient.
First reported by FirstWord Pharma, the computer program is capable of predicting how tumors could become resistant to treatment before it would ever become evident in a clinical trial.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,